Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONStandard

BECLOMETHASONE DIPROPIONATE

BECLOMETHASONE DIPROPIONATE

Standard Dose
0.08MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview BECLOMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 213811 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.08MG/INH Sponsor AMNEAL IRELAND LTD Submission history Latest submission status date: 2025-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview BECLOMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 213811 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.08MG/INH Sponsor AMNEAL IRELAND LTD Submission history Latest submission status date: 2025-12-16 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
BECLOMETHASONE DIPROPIONATE (BECLOMETHASONE DIPROPIONATE) | Drug Monograph | MedicHelpline